Mental Health | Synthetic drugs pose regulatory, diagnostic challenges
Mental Health | Designer drugs, especially synthetic opioids and cannabinoids, are presenting increasing challenges to psychiatrists treating patients with overdoses or psychiatric adverse effects.
In 2017, synthetic opioids caused more than 28,000 deaths in the United States, more than any other type.